Genomic rearrangement of TMPRSS2 fusions with oncogenic ETS factors: Evidence of epigenetic programming of potential therapeutic significance in prostate cancer

被引：0
|
作者：
Gupta, Santosh K. [1 ]
Wol, Maija [1 ]
Ljlin, Ktsitiina [1 ]
Nees, Matthias [1 ]
Kallioniemi, Olli [1 ]
机构：
[1] Univ Turku, SF-20500 Turku, Finland
来源：
CELLULAR ONCOLOGY | 2008年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [41] Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes
    Penney, Kathryn L.
    Pettersson, Andreas
    Shui, Irene M.
    Graff, Rebecca E.
    Kraft, Peter
    Lis, Rosina T.
    Sesso, Howard D.
    Loda, Massimo
    Mucci, Lorelei A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (05) : 745 - 749
  • [42] TMPRSS2, a serine protease highly expressed in prostate cancer: A potential tar-get for therapy
    True, LD
    Matsumura, M
    Moore, S
    Morrison, M
    Henneberg, R
    Nelson, PS
    MODERN PATHOLOGY, 2003, 16 (01) : 174A - 174A
  • [43] Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
    Bugoye, Fidelis Charles
    Torrorey-Sawe, Rispah
    Biegon, Richard
    Dharsee, Nazima
    Mafumiko, Fidelice
    Kibona, Herry
    Aboud, Said
    Patel, Kirtika
    Mining, Simeon
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [44] Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
    Bilke, Sven
    Schwentner, Raphaela
    Yang, Fan
    Kauer, Maximilian
    Jug, Gunhild
    Walker, Robert L.
    Davis, Sean
    Zhu, Yuelin J.
    Pineda, Marbin
    Meltzer, Paul S.
    Kovar, Heinrich
    GENOME RESEARCH, 2013, 23 (11) : 1797 - 1809
  • [45] Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer
    Helgeson, Beth E.
    Tomlins, Scott A.
    Shah, Nameeta
    Laxman, Bharathi
    Cao, Qi
    Prensner, John R.
    Cao, Xuhong
    Singla, Nirmish
    Montie, James E.
    Varambally, Sooryanarayana
    Mehra, Rohit
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2008, 68 (01) : 73 - 80
  • [46] Detection of TMPRSS2-ETS Fusions by a Multiprobe Fluorescence in Situ Hybridization Assay for the Early Diagnosis of Prostate Cancer A Pilot Study
    Sun, Qi-Peng
    Li, Liao-Yuan
    Chen, Zhong
    Pang, Jun
    Yang, Wei-Jiao
    Zhou, Xiang-Fu
    Qiu, Jian-Guang
    Su, Zu-Lan
    He, Dan
    Gao, Xin
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (05): : 718 - 724
  • [47] Prognostic and predictive molecular biological markers in prostate cancer - significance of expression of genes PCA3 and TMPRSS2
    Soumarova, R.
    Boday, A.
    Krhutova, V.
    Janotova, A.
    Dvorakova, M.
    Jaluvkova, E.
    Stursa, M.
    Perkova, H.
    NEOPLASMA, 2015, 62 (01) : 114 - 118
  • [48] Difference of genomic signatures and opportunities for targeted and immunotherapies in castrate resistant TMPRSS2:ERG fusion positive and TMPRSS2:ERG wild type refractory acinar (CRPC) and neuroendocrine prostate cancer (CRNEPC).
    Bratslavsky, Gennady
    Fisher, Hugh A. G.
    Byler, Timothy
    Jacob, Joseph M.
    Chung, Jon
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Ramkissoon, Shakti
    Suh, James
    Severson, Eric Allan
    Daniel, Sugganth
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Kotula, Leszek
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions
    Zachary R. Chalmers
    Michael C. Burns
    Ericka M. Ebot
    Garrett M. Frampton
    Jeffrey S. Ross
    Maha H. A. Hussain
    Sarki A. Abdulkadir
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 558 - 566
  • [50] Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2: ETS fusion gene markers
    Chan, Sam W.
    Phuong-Nam Nguyen
    Violette, Philippe
    Brimo, Fadi
    Taguchi, Yosh
    Aprikian, Armen
    Chen, Junjian Z.
    CANCER MEDICINE, 2013, 2 (01): : 63 - 75
12345